SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Sean McCarthy will participate on a panel titled "Specialty Pharma Play: Are We Near the End?" at the Bio International Convention in Atlanta, GA
News | 05. 21. 2009
